United States Toxoids Market Report 2016

United States Toxoids Market Report 2016

1 Toxoids Overview

1.1 Product Overview and Scope of Toxoids

1.2 Classification of Toxoids

1.2.1 Type I

1.2.2 Type II

1.2.3 Type III

1.3 Application of Toxoids

1.3.1 Application 1

1.3.2 Application 2

1.3.3 Application 3

1.4 United States Market Size Sales (Value) and Revenue (Volume) of Toxoids (2011-2021)

1.4.1 United States Toxoids Sales and Growth Rate (2011-2021)

1.4.2 United States Toxoids Revenue and Growth Rate (2011-2021)

2 United States Toxoids Competition by Manufacturers

2.1 United States Toxoids Sales and Market Share of Key Manufacturers (2015 and 2016)

2.2 United States Toxoids Revenue and Share by Manufactures (2015 and 2016)

2.3 United States Toxoids Average Price by Manufactures (2015 and 2016)

2.4 Toxoids Market Competitive Situation and Trends

2.4.1 Toxoids Market Concentration Rate

2.4.2 Toxoids Market Share of Top 3 and Top 5 Manufacturers

2.4.3 Mergers & Acquisitions, Expansion

3 United States Toxoids Sales (Volume) and Revenue (Value) by Type (2011-2016)

3.1 United States Toxoids Sales and Market Share by Type (2011-2016)

3.2 United States Toxoids Revenue and Market Share by Type (2011-2016)

3.3 United States Toxoids Price by Type (2011-2016)

3.4 United States Toxoids Sales Growth Rate by Type (2011-2016)

4 United States Toxoids Sales (Volume) by Application (2011-2016)

4.1 United States Toxoids Sales and Market Share by Application (2011-2016)

4.2 United States Toxoids Sales Growth Rate by Application (2011-2016)

4.3 Market Drivers and Opportunities

5 United States Toxoids Manufacturers Profiles/Analysis

5.1 Pfizer, Inc. (US)

5.1.1 Company Basic Information, Manufacturing Base and Competitors

5.1.2 Toxoids Product Type, Application and Specification

5.1.2.1 Type I

5.1.2.2 Type II

5.1.3 Pfizer, Inc. (US) Toxoids Sales, Revenue, Price and Gross Margin (2011-2016)

5.1.4 Main Business/Business Overview

5.2 Bayer HealthCare Pharmaceuticals, Inc. (US)

5.2.2 Toxoids Product Type, Application and Specification

5.2.2.1 Type I

5.2.2.2 Type II

5.2.3 Bayer HealthCare Pharmaceuticals, Inc. (US) Toxoids Sales, Revenue, Price and Gross Margin (2011-2016)

5.2.4 Main Business/Business Overview

5.3 GlaxoSmithKline (UK)

5.3.2 Toxoids Product Type, Application and Specification

5.3.2.1 Type I

5.3.2.2 Type II

5.3.3 GlaxoSmithKline (UK) Toxoids Sales, Revenue, Price and Gross Margin (2011-2016)

5.3.4 Main Business/Business Overview

5.4 AbbVie, Inc. (US)

5.4.2 Toxoids Product Type, Application and Specification

5.4.2.1 Type I

5.4.2.2 Type II

5.4.3 AbbVie, Inc. (US) Toxoids Sales, Revenue, Price and Gross Margin (2011-2016)

5.4.4 Main Business/Business Overview

5.5 Anavex Life Sciences Corp. (US)

5.5.2 Toxoids Product Type, Application and Specification

5.5.2.1 Type I

5.5.2.2 Type II

5.5.3 Anavex Life Sciences Corp. (US) Toxoids Sales, Revenue, Price and Gross Margin (2011-2016)

5.5.4 Main Business/Business Overview

5.6 Baxter International, Inc. (US)

5.6.2 Toxoids Product Type, Application and Specification

5.6.2.1 Type I

5.6.2.2 Type II

5.6.3 Baxter International, Inc. (US) Toxoids Sales, Revenue, Price and Gross Margin (2011-2016)

5.6.4 Main Business/Business Overview

5.7 Biocon (India)

5.7.2 Toxoids Product Type, Application and Specification

5.7.2.1 Type I

5.7.2.2 Type II

5.7.3 Biocon (India) Toxoids Sales, Revenue, Price and Gross Margin (2011-2016)

5.7.4 Main Business/Business Overview

5.8 Eli Lilly (US)

5.8.2 Toxoids Product Type, Application and Specification

5.8.2.1 Type I

5.8.2.2 Type II

5.8.3 Eli Lilly (US) Toxoids Sales, Revenue, Price and Gross Margin (2011-2016)

5.8.4 Main Business/Business Overview

5.9 F. Hoffmann-La Roche Ltd. (Switzerland)

5.9.2 Toxoids Product Type, Application and Specification

5.9.2.1 Type I

5.9.2.2 Type II

5.9.3 F. Hoffmann-La Roche Ltd. (Switzerland) Toxoids Sales, Revenue, Price and Gross Margin (2011-2016)

5.9.4 Main Business/Business Overview

5.10 Genentech (US)

5.10.2 Toxoids Product Type, Application and Specification

5.10.2.1 Type I

5.10.2.2 Type II

5.10.3 Genentech (US) Toxoids Sales, Revenue, Price and Gross Margin (2011-2016)

5.10.4 Main Business/Business Overview

5.11 Janssen Biotech, Inc. (US)

5.12 Kemwell Biopharma (India)

5.13 Novartis (Switzerland)

5.14 Sun Pharmaceutical Industries Ltd. (India)

5.15 Sanofi S.A. (France)

6 Toxoids Manufacturing Cost Analysis

6.1 Toxoids Key Raw Materials Analysis

6.1.1 Key Raw Materials

6.1.2 Price Trend of Key Raw Materials

6.1.3 Key Suppliers of Raw Materials

6.1.4 Market Concentration Rate of Raw Materials

6.2 Proportion of Manufacturing Cost Structure

6.2.1 Raw Materials

6.2.2 Labor Cost

6.2.3 Manufacturing Expenses

6.3 Manufacturing Process Analysis of Toxoids

7 Industrial Chain, Sourcing Strategy and Downstream Buyers

7.1 Toxoids Industrial Chain Analysis

7.2 Upstream Raw Materials Sourcing

7.3 Raw Materials Sources of Toxoids Major Manufacturers in 2015

7.4 Downstream Buyers

8 Marketing Strategy Analysis, Distributors/Traders

8.1 Marketing Channel

8.1.1 Direct Marketing

8.1.2 Indirect Marketing

8.1.3 Marketing Channel Development Trend

8.2 Market Positioning

8.2.1 Pricing Strategy

8.2.2 Brand Strategy

8.2.3 Target Client

8.3 Distributors/Traders List

9 Market Effect Factors Analysis

9.1 Technology Progress/Risk

9.1.1 Substitutes Threat

9.1.2 Technology Progress in Related Industry

9.2 Consumer Needs/Customer Preference Change

9.3 Economic/Political Environmental Change

10 United States Toxoids Market Forecast (2016-2021)

10.1 United States Toxoids Sales, Revenue Forecast (2016-2021)

10.2 United States Toxoids Sales Forecast by Type (2016-2021)

10.3 United States Toxoids Sales Forecast by Application (2016-2021)

10.4 Toxoids Price Forecast (2016-2021)

11 Research Findings and Conclusion

12 Appendix

Author List

Disclosure Section

Research Methodology

Data Source

Disclaimer

Figure Picture of Toxoids

Table Classification of Toxoids

Figure United States Sales Market Share of Toxoids by Type in 2015

Table Application of Toxoids

Figure United States Sales Market Share of Toxoids by Application in 2015

Figure United States Toxoids Sales and Growth Rate (2011-2021)

Figure United States Toxoids Revenue and Growth Rate (2011-2021)

Table United States Toxoids Sales of Key Manufacturers (2015 and 2016)

Table United States Toxoids Sales Share by Manufacturers (2015 and 2016)

Figure 2015 Toxoids Sales Share by Manufacturers

Figure 2016 Toxoids Sales Share by Manufacturers

Table United States Toxoids Revenue by Manufacturers (2015 and 2016)

Table United States Toxoids Revenue Share by Manufacturers (2015 and 2016)

Table 2015 United States Toxoids Revenue Share by Manufacturers

Table 2016 United States Toxoids Revenue Share by Manufacturers

Table United States Market Toxoids Average Price of Key Manufacturers (2015 and 2016)

Figure United States Market Toxoids Average Price of Key Manufacturers in 2015

Figure Toxoids Market Share of Top 3 Manufacturers

Figure Toxoids Market Share of Top 5 Manufacturers

Table United States Toxoids Sales by Type (2011-2016)

Table United States Toxoids Sales Share by Type (2011-2016)

Figure United States Toxoids Sales Market Share by Type in 2015

Table United States Toxoids Revenue and Market Share by Type (2011-2016)

Table United States Toxoids Revenue Share by Type (2011-2016)

Figure Revenue Market Share of Toxoids by Type (2011-2016)

Table United States Toxoids Price by Type (2011-2016)

Figure United States Toxoids Sales Growth Rate by Type (2011-2016)

Table United States Toxoids Sales by Application (2011-2016)

Table United States Toxoids Sales Market Share by Application (2011-2016)

Figure United States Toxoids Sales Market Share by Application in 2015

Table United States Toxoids Sales Growth Rate by Application (2011-2016)

Figure United States Toxoids Sales Growth Rate by Application (2011-2016)

Table Pfizer, Inc. (US) Basic Information List

Table Pfizer, Inc. (US) Toxoids Sales, Revenue, Price and Gross Margin (2011-2016)

Figure Pfizer, Inc. (US) Toxoids Sales Market Share (2011-2016)

Table Bayer HealthCare Pharmaceuticals, Inc. (US) Basic Information List

Table Bayer HealthCare Pharmaceuticals, Inc. (US) Toxoids Sales, Revenue, Price and Gross Margin (2011-2016)

Table Bayer HealthCare Pharmaceuticals, Inc. (US) Toxoids Sales Market Share (2011-2016)

Table GlaxoSmithKline (UK) Basic Information List

Table GlaxoSmithKline (UK) Toxoids Sales, Revenue, Price and Gross Margin (2011-2016)

Table GlaxoSmithKline (UK) Toxoids Sales Market Share (2011-2016)

Table AbbVie, Inc. (US) Basic Information List

Table AbbVie, Inc. (US) Toxoids Sales, Revenue, Price and Gross Margin (2011-2016)

Table AbbVie, Inc. (US) Toxoids Sales Market Share (2011-2016)

Table Anavex Life Sciences Corp. (US) Basic Information List

Table Anavex Life Sciences Corp. (US) Toxoids Sales, Revenue, Price and Gross Margin (2011-2016)

Table Anavex Life Sciences Corp. (US) Toxoids Sales Market Share (2011-2016)

Table Baxter International, Inc. (US) Basic Information List

Table Baxter International, Inc. (US) Toxoids Sales, Revenue, Price and Gross Margin (2011-2016)

Table Baxter International, Inc. (US) Toxoids Sales Market Share (2011-2016)

Table Biocon (India) Basic Information List

Table Biocon (India) Toxoids Sales, Revenue, Price and Gross Margin (2011-2016)

Table Biocon (India) Toxoids Sales Market Share (2011-2016)

Table Eli Lilly (US) Basic Information List

Table Eli Lilly (US) Toxoids Sales, Revenue, Price and Gross Margin (2011-2016)

Table Eli Lilly (US) Toxoids Sales Market Share (2011-2016)

Table F. Hoffmann-La Roche Ltd. (Switzerland) Basic Information List

Table F. Hoffmann-La Roche Ltd. (Switzerland) Toxoids Sales, Revenue, Price and Gross Margin (2011-2016)

Table F. Hoffmann-La Roche Ltd. (Switzerland) Toxoids Sales Market Share (2011-2016)

Table Genentech (US) Basic Information List

Table Genentech (US) Toxoids Sales, Revenue, Price and Gross Margin (2011-2016)

Table Genentech (US) Toxoids Sales Market Share (2011-2016)

Table Janssen Biotech, Inc. (US) Basic Information List

Table Janssen Biotech, Inc. (US) Toxoids Sales, Revenue, Price and Gross Margin (2011-2016)

Table Janssen Biotech, Inc. (US) Toxoids Sales Market Share (2011-2016)

Table Kemwell Biopharma (India) Basic Information List

Table Kemwell Biopharma (India) Toxoids Sales, Revenue, Price and Gross Margin (2011-2016)

Table Kemwell Biopharma (India) Toxoids Sales Market Share (2011-2016)

Table Novartis (Switzerland) Basic Information List

Table Novartis (Switzerland) Toxoids Sales, Revenue, Price and Gross Margin (2011-2016)

Table Novartis (Switzerland) Toxoids Sales Market Share (2011-2016)

Table Sun Pharmaceutical Industries Ltd. (India) Basic Information List

Table Sun Pharmaceutical Industries Ltd. (India) Toxoids Sales, Revenue, Price and Gross Margin (2011-2016)

Table Sun Pharmaceutical Industries Ltd. (India) Toxoids Sales Market Share (2011-2016)

Table Sanofi S.A. (France) Basic Information List

Table Sanofi S.A. (France) Toxoids Sales, Revenue, Price and Gross Margin (2011-2016)

Table Sanofi S.A. (France) Toxoids Sales Market Share (2011-2016)

Table Production Base and Market Concentration Rate of Raw Material

Figure Price Trend of Key Raw Materials

Table Key Suppliers of Raw Materials

Figure Manufacturing Cost Structure of Toxoids

Figure Manufacturing Process Analysis of Toxoids

Figure Toxoids Industrial Chain Analysis

Table Raw Materials Sources of Toxoids Major Manufacturers in 2015

Table Major Buyers of Toxoids

Table Distributors/Traders List

Figure United States Toxoids Production and Growth Rate Forecast (2016-2021)

Figure United States Toxoids Revenue and Growth Rate Forecast (2016-2021)

Table United States Toxoids Production Forecast by Type (2016-2021)

Table United States Toxoids Consumption Forecast by Application (2016-2021)